z-logo
open-access-imgOpen Access
[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain
Author(s) -
Qingfu Deng,
Li Luo,
Zhen Quan,
Nanjing Liu,
Zhongbo Du,
Wei Sun,
Chunli Luo,
Xiaohou Wu
Publication year - 2022
Publication title -
molecular medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.727
H-Index - 56
eISSN - 1791-3004
pISSN - 1791-2997
DOI - 10.3892/mmr.2022.12746
Subject(s) - oncogene , androgen receptor , prostate cancer , cell cycle , cytoplasm , cell , cancer research , biology , cell growth , domain (mathematical analysis) , chromosomal translocation , nuclear receptor , cancer , microbiology and biotechnology , molecular medicine , apoptosis , receptor , transcription factor , genetics , gene , mathematics , mathematical analysis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom